NMS·Healthcare·$1.3B·#386 / 520 in Healthcare
QURE uniQure N.V.
30HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY60
STABILITY30
VALUATION0
GOVERNANCE37
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-40.6%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
89.5%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
9
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
31.9%
73
< 25% strong
Price / Sales
Market cap relative to trailing revenue
81.4x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-1207
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
5.6%
43
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+15.2%
24
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE QURE WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when QURE's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.